Skip to Content


Manufacturer of Controlled Substances; Notice of Application

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 4, 2011, Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Gamma Hydroxybutyric Acid (GHB) (2010)I
Amphetamine (1100)II
Lisdexamfetamine (1205)II
Methylphenidate (1724)II
4-anilino-N-phenethyl-4-piperidine (ANPP) (8333)II
Phenylacetone (8501)II
Codeine (9050)II
Oxycodone (9143)II
Hydromorphone (9150)II
Dextropropoxyphene, bulk II (non-dosage forms) (9273)II
Morphine (9300)II
Oripavine (9330)II
Thebaine (9333)II
Raw Opium (9600)II
Oxymorphone (9652)II
Concentrate of Poppy Straw (9670)II
Sufentanil (9740)II
Fentanyl (9801)II

The company will manufacture the listed controlled substances in bulk for sale to its customers.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than December 6, 2011.

Start Signature

Dated: September 28, 2011.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 2011-26005 Filed 10-6-11; 8:45 am]